Development and Validation of a Predictive Nomogram for Myelosuppression Risk in Chronic Hepatitis B Patients Treated with Peginterferon
Jiwei Fu,1,* Ting Deng,2,* Ting Zheng,1 Pei Shi,1 Wentao Zhu,1 Mengyu Tao,1 Zhilong Wen,1 Xiaoping Wu1 1Department of Infectious Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, 330006, People’s Republic of China; 2Sec...
Saved in:
| Main Authors: | Fu J, Deng T, Zheng T, Shi P, Zhu W, Tao M, Wen Z, Wu X |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | Infection and Drug Resistance |
| Subjects: | |
| Online Access: | https://www.dovepress.com/development-and-validation-of-a-predictive-nomogram-for-myelosuppressi-peer-reviewed-fulltext-article-IDR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peginterferon and Chinese herbs exert a combinatorial effect in HBeAg-positive chronic hepatitis B
by: Yingfeng An, et al.
Published: (2016-04-01) -
Risk factors analysis and nomogram development for myelosuppression in diffuse large B-cell lymphoma patients undergoing first-line chemotherapy: a dual-centre retrospective cohort study
by: Xuexing Wang, et al.
Published: (2025-06-01) -
Efficacy and safety of pegylated-interferon alpha therapy in patients with chronic hepatitis B in recource-limited settings- Serbian single-center experience
by: Bojović Ksenija, et al.
Published: (2020-01-01) -
The remodeling of B-cell subsets was correlated with the clearance of hepatitis B antigen during pegylated IFN α-2a therapy in CHB patients
by: Lei Tan, et al.
Published: (2025-12-01) -
Alopecia as the first manifestation of azathioprine myelosuppression in a genetically predisposed patient
by: Debashish Mishra, et al.
Published: (2019-01-01)